European and Japanese scientists have figured out how to "reset" human pluripotent stem cells, turning back the clock on cells so that they revert to their original state at the height of their development potential.
Researchers have found a molecular process that prompts blood stem cells to self-renew while retaining their stem cell-like properties, a discovery that could allow scientists to regrow enough cells in a lab for transplantation.
Following controversy over irreproducible results in a paper that detailed an easy way to create embryonic-like stem cells by shocking adult cells with an acid bath, the Japanese RIKEN Center for Developmental Biology said it is scaling down its stem cell research.
Mesenchymal stem cells may eventually be able to grow and strengthen muscles in humans, according to researchers at the University of Illinois. In mice, an injection of such stem cells helped rejuvenate skeletal muscle after exercise.
Investigators at the University of Wisconsin-Madison have figured out a way to genetically program stem cells into both red and white cells that make up human blood.
Researchers have figured out a way to identify stem cells in tissue from deceased human donors and use them to regrow anatomically correct, fully functional human corneas in mice.
A chemical switch that controls the transformation of neural stem cells into neurons and keeps existing nerve cells in the brain alive may be a viable target for neurodegenerative disorders such as Alzheimer's, Parkinson's and autism.
Researchers from ImStem Biotechnology, University of Connecticut Health Center and Advanced Cell Technology have successfully treated mice with multiple sclerosis using human embryonic stem cells derived from mesenchymal stem cells, known as hES-MSCs.
Scientists at the University of Missouri have successfully transplanted and grown stem cells in pigs, pointing the way to a similar method that could eventually be used in people.
Researchers from Italy's San Raffaele Telethon Institute for Gene Therapy and Sangamo BioSciences have used a gene editing technique to correct a genetic defect in stem cells from an individual with X-linked severe combined immunodeficiency.